PD-1 and PDL-1 Immune Checkpoint Inhibitors: Emerging Hope for the Future of Lung Cancer Immunotherapy. Faculty of Medicine, Tadulako University, P-ISSN: 2407-8441 and e-ISSN 2502-0749 2025, 11 (3), 445-454. https://doi.org/10.22487/htj.v11i3.1723.